View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
January 28, 2016

Pullman Regional Hospital uses Christie VeinViewer vein finder technology

US-based Pullman Regional Hospital has acquired new technology, Christie VeinViewer Vision2, as part of its focus on children's health.

VeinViewer

US-based Pullman Regional Hospital has acquired new technology, Christie VeinViewer Vision2, as part of its focus on children’s health.

Free Whitepaper
img

How is AI impacting the future of Healthcare?

The applications of AI in healthcare are many, with the potential to transform key aspects of the industry and drive innovation. Uses include data management, remote surgery, diagnostic and procedural AI assistants, drug discovery, and clinical trial design. GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019.

GlobalData’s AI in Healthcare Thematic Research report provides you with an in-depth lens into the impact of artificial intelligence on the industry. We highlight both the challenges and opportunities associated with the innovative technology now, and in the future. Our report also covers:

  • Major players and companies
  • Market size and growth forecasts
  • Case studies
  • Sector scorecard

According to our recent survey, almost two-thirds of pharma professionals expect AI to be the leading disruptive technology in the pharma sector over the next two years. With threats to the industry exacerbated by the COVID-19 pandemic, you should be proactive in adapting strategies and processes to help you remain competitive. Download the full report to get ahead of the competition.

by GlobalData
Enter your details here to receive your free Whitepaper.

The technology is expected to make venipuncture easier and increase first stick success by up to 100%.

The technology will be helpful when drawing blood or inserting an IV on a child, which can be difficult for various reasons, including smaller veins, subcutaneous fat and greater elasticity of skin.

The technology can also be used on all patients, including adults who may have small or hard to find veins.

It is designed to decrease anxiety experienced by patients, parents and staff when drawing blood or starting an IV.

"The technology is expected to make venipuncture easier and increase first stick success by up to 100%."

According to reports, first time stick rates have increased from 31% to 83% using the technology. In one study, a hospital that started using VeinViewer more than doubled their patient satisfaction scores after one month.

VeinViewer Vision2 uses harmless near-infrared light to detect patient veins and projects a real-time, high definition image of the vein pattern directly on the skin surface for providers to quickly find more options for accessing a patient’s veins.

The non-invasive, hands-free device is designed to be moved across hospital departments, such as the emergency department, laboratory, and medical / surgical units.

Christie Medical Holdings discovers, develops and commercialises medical technologies and its lead product, VeinViewer, allows healthcare providers to clearly see accessible vasculature as a real time HD image, directly on the surface of the skin.


Image: VeinViewer vein finder technology will be used as part of the hospital’s focus on children’s health. Photo: courtesy of Christie Medical Holdings.

Related Companies

Free Whitepaper
img

How is AI impacting the future of Healthcare?

The applications of AI in healthcare are many, with the potential to transform key aspects of the industry and drive innovation. Uses include data management, remote surgery, diagnostic and procedural AI assistants, drug discovery, and clinical trial design. GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019.

GlobalData’s AI in Healthcare Thematic Research report provides you with an in-depth lens into the impact of artificial intelligence on the industry. We highlight both the challenges and opportunities associated with the innovative technology now, and in the future. Our report also covers:

  • Major players and companies
  • Market size and growth forecasts
  • Case studies
  • Sector scorecard

According to our recent survey, almost two-thirds of pharma professionals expect AI to be the leading disruptive technology in the pharma sector over the next two years. With threats to the industry exacerbated by the COVID-19 pandemic, you should be proactive in adapting strategies and processes to help you remain competitive. Download the full report to get ahead of the competition.

by GlobalData
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management